期刊文献+

继发性肺结核患者外周血中CD4^+CD25^+FoxP3^+Tregs细胞亚群分析 被引量:2

The peripheral blood CD4^+CD25^+FoxP3^+ Tregs cell subgroup analysis in secondary pulmonary tuberculosis patients
在线阅读 下载PDF
导出
摘要 目的探讨继发性肺结核患者外周血中CD4^+CD25^+FoxP3^+Tregs细胞亚群的水平。方法随机收集2013年8月至2015年6月就诊的住院或门诊继发性肺结核患者共132例,其中耐药继发性肺结核70例,非耐药继发性肺结核62例,并收集165例健康体检人群。采用流式细胞术检测三组对象外周血中CD4^+CD25^+FoxP3^+Tregs细胞表达水平。结果耐药继发性肺结核组外周血中CD4^+CD25^+FoxP3^+Tregs表达水平为(17.3±1.92)%,非耐药继发性肺结核组为(12.7±2.06)%,健康人群组为(5.96±2.85)%,三组表达水平之间差异均有统计学意义(P<0.05)。结论继发性肺结核患者外周血中CD4^+CD25^+FoxP3^+Tregs细胞表达水平明显增高,这可能与继发性肺结核的发生和发展有密切关系,对其诊断和治疗有重要意义。 Objective To investigate the expression level of peripheral blood CD4^+CD25^+FoxP3^+Treg cells in patients with secondary pulmonary tuberculosis.Methods A total of 132 patients from August 2013 to June 2015 with secondary pulmonary tuberculosis were collected,including 70 cases with drug resistance and 62 cases without drug resistance,and 165 cases of healthy patients were also collected.Flow cytometry test was performed to observe peripheral blood CD4^+CD25^+FoxP3^+Treg cells and the differences between the three sets were compared.Results The expression level of peripheral blood CD4^+CD25^+FoxP3^+Treg cells in patients with secondary drug resistance pulmonary tuberculosis group was 17.3%±1.92%,non resistant secondary pulmonary tuberculosis group 12.7%±2.06%,healthy people group 5.96%±2.85%.The difference had statistical significance(P〈0.05).Conclusion The expression level of peripheral blood CD4^+CD25^+FoxP3^+Treg cells in patients with secondary pulmonary tuberculosis is high,and this may be related to the occurrence and development of secondary pulmonary tuberculosis of secondary pulmonary tuberculosis.
出处 《临床和实验医学杂志》 2016年第24期2440-2442,共3页 Journal of Clinical and Experimental Medicine
关键词 继发性肺结核 CD4^+CD25^+FoxP3^+Tregs细胞 流式细胞术 Secondary pulmonary tuberculosis CD4^+CD25^+FoxP3^+ Treg cells Flow cytometry
  • 相关文献

参考文献6

二级参考文献41

  • 1陈心春,周伯平,邓群益,李美忠,张维,付向东,蔡雄茂,王火生,余卫业.CD4^+CD25^+调节性T细胞对肺结核患者特异细胞免疫的调节作用[J].中国防痨杂志,2008,30(3):165-169. 被引量:10
  • 2Chan ED,Iseman MD.Current medical treatment for tuberculosis.BMJ,2002,325(30):1282-1286.
  • 3Boussiotis,V.A.,E.Y.Tsai,E.J.Yunis,et al.IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.J Clin Invest,2000,105(9):1317-1325.
  • 4Baecher-Allan,C.,J.A.Brown,G.J.Freeman,et al.CD4 +CD25high regulatory cells in human peripheral blood.J Immunol,2001,167(3):1245-1253.
  • 5Sakaguchi S.Naturally arising Foxp3-expressing CD25 + CD4 +regulatory T cells in immunological tolerance to self and non-self.Nat Immunol,2005,6(4):345-352.
  • 6Fehervari Z,Sakaguchi S.CD4 + Tregs and immune control.J Clin Invest,2004; 114(9):1209-1217.
  • 7Davidson TS,Dipaolo RJ,Andersson J,et al.Cutting edge:IL-2 is essential for TGF-beta -mediated induction of Foxp3 + T regulatory cells.J Immunol,2007,178(7):4022-4026.
  • 8Sakaguchi S,Sakaguchi N,Shimizu J,et al.Immunologic tolenrance maintained by CD25 + CD4 + regulatory T cells:their common rloe in controlling autoimmunity,tumor immunity and transplantation tolerance.Immunol Rev.2001,182(1):18-32.
  • 9Guyot-Revol V,Innes JA,Hackforth S,et al.Regulatory T Cells Are Expanded in Blood and Disease Sites in Patients with Tuberculosis.Am.J.Respir.Crit.Care Med.,2006,173:803 -810.
  • 10Riss GL, Chang DI, Wevers C, et al. Opioid maintenance therapy restores CD4 + T cell function by normalizing CD4 + CD25high regulatory T cell frequencies in heroin user[J]. Brain Behav Immun, 2012, 26(6): 972 -978.

共引文献26

同被引文献25

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部